Trial Profile
Clinical Trials Insight: 700048839
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2010
Price :
$35
*
At a glance
- Drugs Etazolate (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors ExonHit Therapeutics
- 16 Sep 2009 New trial record.